Patients in rural regions of the U.S. already struggle to access healthcare services, now both rural patients and their physicians are waiting to access a new Alzheimer’s drug, according to a May 7 report from The Wall Street Journal.
Read the full post on Becker's Hospital Review - Healthcare News
